Loading...

About Carolina BioOncology Institute

Carolina BioOncology Institute is reimagining access to groundbreaking cancer treatments, a disruptive approach to bench-to-bedside medicine. Our unique business model leverages curated access to Phase I Clinical Trials with on site research and clinical laboratory support for the treatment of human disease.

Patient & Sponsor Services

Clinical Trials

Patients participating in a clinical trial have the opportunity to receive new research treatments before they are widely available. With Phase I clinical trial capabilities at our facility in Huntersville, NC, we’re able to quickly enroll patients in the newest trials and provide the highest quality of patient care in a community-based setting.

Learn More

CLIA Laboratory Services

Our on site Clinical Laboratory can provide routine patient sample analyses including hematology, urinalysis, metabolic testing, and other diagnostic services. The facility is also high-complexity certified in Immunology and can perform CELLSEARCH CTC enumeration and COVID-19 screening as requested or provider-ordered.

Learn More

Contract Research

Human Applications Lab (HAL) staff perform translational Tumor Immunology research for internal projects and biopharmaceutical sponsors. Expert staff are trained in GDP, GLP, and cGMP regulations in order to provide services like cell processing, technology transfer, process scale-up, and other IND-enabling solutions.

Learn More

In The News

AABB-Accredited Facility Biotherapies Services Spotlight Series February 2025: Carolina BioOncology Institute

AABB – 2/1/25

In 2005, John Powderly, MD, founded both CBOI and BioCytics as reflections of the same vision to deliver autologous immune cell therapies manufactured at the point of care for early phase clinical trials. He states that, “We believe the future of bespoke regenerative medicine depends upon regional human application labs as an efficient, affordable and accessible delivery system. Our recent AABB accreditation is another step closer to realizing our vision to enable future cellular immune cures for solid tumor cancer patients.”

Full Article

National Minority Quality Forum’s announces a collaboration with Carolina BioOncology Institute

NMQF By Adjoa Kyerematen – 10/24/24

NMQF, Carolina BioOncology, and BioCytics are collaborating to create a national registry and biorepository for CSSI, collecting critical clinical, genetic, and demographic data from 20 communities. This biorepository will support research on cancer risk factors, driving logistical changes to ease the development and deployment of new detection technologies and precision treatments. De-identified data will be accessible to researchers, helping ensure that advancements in cancer care reach underserved communities. The findings will be used to improve local cancer care logistics, advancing the Cancer Moonshot’s goal of reducing cancer mortality in these populations by addressing bottlenecks through a data-driven approach.

Full Article

Highlights from the September 9th Event: UNC Charlotte Dubois Center Through NCBiotech

The Center for Biomedical Engineering and Science – 9/9/24

Full Article

Featured Practice: Carolina BioOncology Institute & BioCytics Human Applications Lab

Charlotte Mag Content Studio – 7/1/24

Full Article
See All News

View Our Facilities